These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10051373)

  • 1. Dopamine modulates peripheral purinergic neurotransmission through multiple presynaptic receptors: tissue-dependent effects.
    El-Mas MM; Elmallah AI; Omar AG; Sharabi F
    Pharmacol Res; 1999 Jan; 39(1):11-9. PubMed ID: 10051373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractility of urinary bladder and vas deferens after sensory denervation by capsaicin treatment of newborn rats.
    Ziganshin AU; Ralevic V; Burnstock G
    Br J Pharmacol; 1995 Jan; 114(1):166-70. PubMed ID: 7712013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prazosin-induced blockade of extraneuronal uptake facilitates dopaminergic modulation of muscle twitches in rat vas deferens.
    Elmallah AI; Sharabi F; Omar AG; El-Mas MM
    J Pharm Pharmacol; 1995 Nov; 47(11):932-6. PubMed ID: 8708988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neocuproine, a copper (I) chelator, potentiates purinergic component of vas deferens contractions elicited by electrical field stimulation.
    Göçmen C; Kumcu EK; Büyüknacar HS; Onder S; Singirik E
    Pharmacology; 2005 Oct; 75(2):69-75. PubMed ID: 16020948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha,beta-methylene ATP on potentiation of contractions to field stimulation of rat vas deferens by carbachol.
    Lee CM; Cheung WT
    Zhongguo Yao Li Xue Bao; 1989 Jan; 10(1):17-22. PubMed ID: 2816395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by ethanol of contractions of rat vas deferens: no evidence for selective blockade of P2X-purinoceptors.
    Bültmann R; Szabo B; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):527-33. PubMed ID: 8391654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hypophysectomy on purinergic and noradrenergic contractility of the rat vas deferens.
    Ralevic V; Burnstock G
    J Auton Pharmacol; 1996 Aug; 16(4):191-6. PubMed ID: 8953373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens.
    György L; Orr Z; Folly G; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):55-64. PubMed ID: 6268006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two phases of contractile response in rat isolated vas deferens and their regulation by adenosine and alpha-receptors.
    Major TC; Weishaar RE; Taylor DG
    Eur J Pharmacol; 1989 Aug; 167(3):323-31. PubMed ID: 2572433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prejunctional inhibitory dopamine receptors in the rat isolated vas deferens.
    Tayo FM
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):28-37. PubMed ID: 6121537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.
    Guitart M; Giraldo J; Goñalons E; Vila E; Badia A
    Br J Pharmacol; 1999 Oct; 128(4):873-80. PubMed ID: 10556921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cholinergic and purinergic neurotransmission in pathologic bladder of chronic spinal rabbit.
    Yokota T; Yamaguchi O
    J Urol; 1996 Nov; 156(5):1862-6. PubMed ID: 8863633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
    Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus.
    Conceição IM; Jurkiewicz A; Fonseca DR; Opperman AR; Freitas TA; Lebrun I; Garcez-do-Carmo L
    Br J Pharmacol; 2005 Feb; 144(4):519-27. PubMed ID: 15678093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.
    Docherty JR
    Br J Pharmacol; 1984 May; 82(1):15-23. PubMed ID: 6145465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purinergic modulation of field stimulation responses of rat and human vas deferens smooth muscle.
    Lynch M; Huddart H
    Gen Pharmacol; 1991; 22(5):869-72. PubMed ID: 1761193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) impairs neurotransmission in the vas deferens of the rat.
    Landa ME; Fiszman ML
    Gen Pharmacol; 1993 May; 24(3):733-8. PubMed ID: 8396060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P2X1 receptors localized in lipid rafts mediate ATP motor responses in the human vas deferens longitudinal muscles.
    Donoso MV; Norambuena A; Navarrete C; Poblete I; Velasco A; Huidobro-Toro JP
    Biol Reprod; 2014 Feb; 90(2):23. PubMed ID: 24352557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.
    Lundberg JM; Hua XY; Franco-Cereceda A
    Acta Physiol Scand; 1984 Aug; 121(4):325-32. PubMed ID: 6091417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by dopamine of the neurotransmission in the rat vas deferens.
    Dopico AM; Fiszman ML; Stefano FJ
    Acta Physiol Pharmacol Latinoam; 1986; 36(3):257-64. PubMed ID: 3033993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.